FDA label
What is Ibsrela used for?
Ibsrela contains tenapanor. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “IBSRELA is indicated for treatment of irritable bowel syndrome with constipation (IBS-C) in adults.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Ibsrela?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Ibsrela, tablet
Indications and Usage, quoted from the label by Ardelyx, Inc. (NDA211801). Cross-references to other label sections are left out.
IBSRELA is indicated for treatment of irritable bowel syndrome with constipation (IBS-C) in adults.
Source: DailyMed label, set id 2102da5f-a1a0-4ac7-a1f6-38698cf7273a, version 11, effective May 28, 2025. NDC 73154-050, one of 1 listing for this product.
Questions
What is Ibsrela used for?
The FDA label says: “IBSRELA is indicated for treatment of irritable bowel syndrome with constipation (IBS-C) in adults.”
What drug class is Ibsrela?
FDA lists tenapanor in the Sodium-Hydrogen Exchanger 3 Inhibitor established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.